Flow cytometry analysis showed that chimera treatment exhibited a significant reduction in both the frequency and absolute number of FoxP3+CD4+ Treg cells per milligram of tumor tissue compared to the PBS control group (Fig. 4a-b). This evidence concerns the gene CD4 and neoplasm.